UK Regulatory System Progress And New MedTech Directorate Unveiled At Industry Meeting
More momentum behind post-EU regulatory arrangements at home and globally
Executive Summary
In the three months since Brexit, UK medtech stakeholders have seen the beginnings of new regulations, foreign trade plans being put in place, and perhaps new perceptions of medtech’s value.
You may also be interested in...
Hoping For A New Dawn In UK’s Value-Based Procurement
The UK’s MedTech Directorate is undergoing a partial relaunch, with a new director set to take the reins and a new strategy being finalized. The medtech industry hopes the renewed impetus will put long-overdue attention to value-based procurement for medtech goods.
Startup Spotlight: INBRAIN Hopes To Leapfrog Brain Electrode Competition
By utilizing the properties of graphene, INBRAIN hopes to develop improved electrodes implanted in the brain, raising the potential of neuromodulation for treating complex neurological disorders.
UK Medicines And Medical Devices Act 2021 Passed Into Law
The duties of the new commissioner for patient safety have been prioritized in the UK’s Medicines and Medical Devices bill, which has been given Royal Assent.